Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Veru Inc. (VERU)

2.875   -0.005 (-0.17%) 09-20 00:35
Open: 2.9 Pre. Close: 2.88
High: 3.02 Low: 2.82
Volume: 1,549,653 Market Cap: 201M
Veru, Inc. is an oncology and urology biopharmaceutical company. The company is headquartered in Miami, Florida and currently employs 386 full-time employees. Its oncology drug candidates include VERU-111, an oral alpha and beta tubulin inhibitor, which is in a Phase 1b/2 study for the treatment of metastatic castration resistant prostate cancer; Zuclomiphene citrate, which is in a Phase II clinical trial for the treatment of hot flashes in men, and VERU-100, which is a gonadotropin-releasing hormone (GnRH) antagonist. Its urology specialty pharmaceutical drug candidate is Tadalafil and Finasteride Combination (TADFIN), which is a tadalafil and finasteride combination oral capsule for the treatment of men with benign prostatic hyperplasia. Its commercial products include the FC2 Female/Internal Condom for prevention of pregnancy and sexually transmitted infections, and PREBOOST wipes for the prevention of premature ejaculation.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.024 - 3.039 3.039 - 3.053
Low: 2.784 - 2.801 2.801 - 2.816
Close: 2.851 - 2.881 2.881 - 2.906

Technical analysis

as of: 2020-09-18 4:36:48 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 3.53     One year: 4.12
Support: Support1: 2.74    Support2: 2.56
Resistance: Resistance1: 3.02    Resistance2: 3.53
Pivot: 2.75
Moving Average: MA(5): 2.81     MA(20): 2.74
MA(100): 3.20     MA(250): 3.07
MACD: MACD(12,26): -0.02     Signal(9): -0.05
Stochastic oscillator: %K(14,3): 73.23     %D(3): 70.28
RSI: RSI(14): 53.98
52-week: High: 4.74  Low: 1.85  Change(%): 41.6
Average Vol(K): 3-Month: 80572  10-Days: 44952

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
VERU has closed below upper band by 6.0%. Bollinger Bands are 49.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to VERU's normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sat, 19 Sep 2020
The Exact Trigger that Indicates Volatility in Veru Inc - CMLViz.com - CML News

Fri, 18 Sep 2020
Do Veru Inc. (VERU) beta value of 0.16 signposts another twist? - The InvestChronicle

Fri, 18 Sep 2020
Is Veru Inc (VERU) Stock About to Get Hot Friday? - InvestorsObserver

Fri, 18 Sep 2020
Veru (VERU) Announces ESMO Congress 2020 Oral Presentation of Positive Clinical Results from its VERU-111 Phase 1b Study in Metastatic Prostate Cancer - StreetInsider.com

Fri, 18 Sep 2020
Veru Announces ESMO Congress 2020 Oral Presentation of Positive Clinical Results from its VERU-111 Phase 1b Study in Metastatic Prostate Cancer - GlobeNewswire

Thu, 17 Sep 2020
Health Check: How Prudently Does Veru (NASDAQ:VERU) Use Debt? - Yahoo Eurosport UK

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 70
Shares Float (M) 53
% Held by Insiders 24.77
% Held by Institutions 13.93
Shares Short (K) 2,000
Shares Short P. Month (K) 1,670

Stock Financials

EPS -0.156
EPS Est This Year -0.170
EPS Est Next Year -0.080
Book Value (p.s.) 0.590
Profit Margin -25.78
Operating Margin -12.47
Return on Assets (ttm) -5.2
Return on Equity (ttm) -26.8
Qtrly Rev. Growth 6.1
Gross Profit (p.s.) 0.310
Sales Per Share 0.566
EBITDA (p.s.) -0.064
Qtrly Earnings Growth
Operating Cash Flow (M) -3
Levered Free Cash Flow (M) -2

Stock Valuations

PE Ratio -18.43
PEG Ratio
Price to Book value 4.87
Price to Sales 5.07
Price to Cash Flow -79.07

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date 2014-05-06
Ex-Dividend Date 2014-04-27
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.